ASUS (華碩) has successfully secured U.S. Food and Drug Administration (FDA) Class II 510(k) clearance for its LU800 series handheld wireless ultrasound. This approval marks a significant victory in the company’s smart healthcare roadmap, validating the clinical credibility and regulatory compliance of its portable imaging technology.

Strategic & Technical Highlights:

• Clinical Utility: The LU800 series is designed for point-of-care diagnostics, combining high-resolution medical imaging with a portable, wireless form factor.
• AI-Driven Navigation: ASUS is integrating "Ultrasound Scanning AI Navigation" to provide real-time guidance. This lowers the barrier to entry for non-specialists, addressing the global gap in medical manpower and heavy clinical workloads.
• Ecosystem Integration: COO Joe Hsieh emphasized that ASUS will continue to leverage its hardware-software synergy to develop "fast-landing" solutions. The focus remains on AI algorithms, medical image processing, and cross-system integration to transform traditional diagnostic workflows.

Resource: 華碩投入智慧醫療有成，手持超音波產品獲美國 FDA 上市許可